Cargando…
Clinical Routine Application of the Second-generation Neuroendocrine Markers ISL1, INSM1, and Secretagogin in Neuroendocrine Neoplasia: Staining Outcomes and Potential Clues for Determining Tumor Origin
Neuroendocrine neoplasms (NENs) have traditionally been identified via expression of proteins associated to the regulation of secretory vesicles and granules. We report the clinical usage of the “second-generation” proteins ISL LIM homeobox 1 (ISL1), INSM transcriptional repressor 1 (INSM1), and sec...
Autores principales: | Juhlin, Carl Christofer, Zedenius, Jan, Höög, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665972/ https://www.ncbi.nlm.nih.gov/pubmed/32813226 http://dx.doi.org/10.1007/s12022-020-09645-y |
Ejemplares similares
-
Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
por: Juhlin, Carl Christofer, et al.
Publicado: (2022) -
Metastatic malignant melanoma with neuroendocrine differentiation: a case report and review of the literature
por: Juhlin, Carl Christofer, et al.
Publicado: (2020) -
Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation
por: Juhlin, Carl Christofer
Publicado: (2021) -
INSM1, a Novel Biomarker for Detection of Neuroendocrine Neoplasms: Cytopathologists’ View
por: Maleki, Zahra, et al.
Publicado: (2021) -
Immunosensitivity and specificity of insulinoma-associated protein 1 (INSM1) for neuroendocrine neoplasms of the uterine cervix
por: Kuji, Shiho, et al.
Publicado: (2022)